ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO380

Prognostic Value of Triglyceride Glucose (TyG) Index in a Population with CKD

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Lee, Jeong-Yeun, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Kim, Jin Sug, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Kim, Hyun Kyu, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Kim, Dae Kyu, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Yoon, Soo-Young, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Jeong, Kyunghwan, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
  • Hwang, Hyeon Seok, Kyung Hee University Medical Center, Dongdaemun-gu, Seoul, Korea (the Republic of)
Background

The triglyceride glucose (TyG) index has been proposed as a reliable marker of insulin resistance and an independent predictor of cardiovascular (CV) event. However, its prognostic value in chronic kidney disease (CKD) remains unclear. This study aims to assess predictive value of the TyG index for clinical outcomes in CKD population.

Methods

This study was conducted using the Korean National Health Insurance Service database. 91,070 individuals with CKD who underwent a national health examination between 2012 and 2015 were enrolled. The study population was divided into four groups based on the quartile of TyG index levels. The primary outcome was a CV event, including myocardial infarction and stroke, and the secondary outcomes were progression to end-stage kidney disease (ESKD) and all-cause mortality.

Results

During a median follow-up time of 80.4 months, CV event, progression to ESKD, and all-cause mortality occurred in 11,676 (12.8%), 3,776 (4.1%) and 13,481 (14.8%) cases, respectively. The cumulative event rate of cardiovascular events, progression to ESKD, and all-cause mortality was the highest among population with TyG quartile 4 (all P < 0.001). In multivariate Cox-regression analysis, a higher TyG index was associated with an increased risk of CV event. Compared with participants in the lowest quartile of TyG index, hazard ratios (HR) and 95% confidence intervals (CI) for CV event were 1.063 (1.008-1.121), 1.104 (1.047-1.165), 1.290 (1.222-1.363) for those in second, third, and fourth quartile of TyG index. The risk of progression to ESKD was also increased as TyG quartile increased [adjusted HR (95% CI) 1.143 (1.027-1.271), 1.282 (1.143-1.437), and 1.826 (1.635-2.039)] for population with TyG quartile 2, 3, and 4, respectively]. However, there was no significant association with an increase in the risk of all-cause mortality.

Conclusion

The TyG index serves as a valuable predictor of CV event, progression to ESKD and all-cause mortality in CKD population.